121 related articles for article (PubMed ID: 19521129)
1. [Molecular diagnostics and imaging].
Fink C; Fisseler-Eckhoff A; Huss R; Nestle U
Onkologie; 2009; 32 Suppl 1():3-8. PubMed ID: 19521129
[TBL] [Abstract][Full Text] [Related]
2. [An approach to individualised therapy of non-small cell lung carcinoma (NSCLC)--relevance of molecular predictive and prognostic factors].
Zirlik S; Lampert S; Hahn EG; Wiest GH; Brückl WM
Pneumologie; 2007 Nov; 61(11):731-8. PubMed ID: 17948172
[TBL] [Abstract][Full Text] [Related]
3. Expression of TS, RRM1, ERCC1, TUBB3 and STMN1 Genes in Tissues of Non-small Cell Lung Cancer and its Significance in Guiding Postoperative Adjuvant Chemotherapy.
Zou ZQ; Du YY; Sui G; Xu SN
Asian Pac J Cancer Prev; 2015; 16(8):3189-94. PubMed ID: 25921119
[TBL] [Abstract][Full Text] [Related]
4. [Response judgement - conventional versus new methods].
Diederich S; Engeser P; Junker K; Passlick B; Pfluger T; Pottgen C; Reck M
Onkologie; 2009; 32 Suppl 1():9-17. PubMed ID: 19521130
[TBL] [Abstract][Full Text] [Related]
5. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Planchard D; Popat S; Kerr K; Novello S; Smit EF; Faivre-Finn C; Mok TS; Reck M; Van Schil PE; Hellmann MD; Peters S;
Ann Oncol; 2018 Oct; 29(Suppl 4):iv192-iv237. PubMed ID: 30285222
[No Abstract] [Full Text] [Related]
6. Non-small-cell lung cancer.
Goldstraw P; Ball D; Jett JR; Le Chevalier T; Lim E; Nicholson AG; Shepherd FA
Lancet; 2011 Nov; 378(9804):1727-40. PubMed ID: 21565398
[TBL] [Abstract][Full Text] [Related]
7. Treatment of advanced (stages III and IV) non-small-cell lung cancer.
Sweeney CJ; Sandler AB
Curr Probl Cancer; 1998; 22(2):85-132. PubMed ID: 9580849
[TBL] [Abstract][Full Text] [Related]
8. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC).
Felip E; Stahel RA; Pavlidis N;
Ann Oncol; 2005; 16 Suppl 1():i28-9. PubMed ID: 15888743
[No Abstract] [Full Text] [Related]
9. Combined analysis of rearrangement of ALK, ROS1, somatic mutation of EGFR, KRAS, BRAF, PIK3CA, and mRNA expression of ERCC1, TYMS, RRM1, TUBB3, EGFR in patients with non-small cell lung cancer and their clinical significance.
Zhang Q; Sun T; Kang P; Qian K; Deng B; Zhou J; Wang R; Jiang B; Li K; Liu F; Wu S; Tan Q
Cancer Chemother Pharmacol; 2016 Mar; 77(3):583-93. PubMed ID: 26842788
[TBL] [Abstract][Full Text] [Related]
10. Staging and prognosis in lung cancer: making the complex accessible.
Langer CJ
Cancer Treat Res; 2001; 105():53-94. PubMed ID: 11224997
[No Abstract] [Full Text] [Related]
11. Non-small cell lung cancer.
Ettinger DS; Akerley W; Borghaei H; Chang AC; Cheney RT; Chirieac LR; D'Amico TA; Demmy TL; Ganti AK; Govindan R; Grannis FW; Horn L; Jahan TM; Jahanzeb M; Kessinger A; Komaki R; Kong FM; Kris MG; Krug LM; Lennes IT; Loo BW; Martins R; O'Malley J; Osarogiagbon RU; Otterson GA; Patel JD; Pinder-Schenck MC; Pisters KM; Reckamp K; Riely GJ; Rohren E; Swanson SJ; Wood DE; Yang SC; Hughes M; Gregory KM;
J Natl Compr Canc Netw; 2012 Oct; 10(10):1236-71. PubMed ID: 23054877
[TBL] [Abstract][Full Text] [Related]
12. Preliminary activity of capmatinib with gefitinib in NSCLC.
Burki TK
Lancet Oncol; 2018 Oct; 19(10):e517. PubMed ID: 30197173
[No Abstract] [Full Text] [Related]
13. Histology-related associations of ERCC1, RRM1, and TS biomarkers in patients with non-small-cell lung cancer: implications for therapy.
Maus MK; Mack PC; Astrow SH; Stephens CL; Zeger GD; Grimminger PP; Hsiang JH; Huang E; Li T; Lara PN; Danenberg KD; Gandara DR
J Thorac Oncol; 2013 May; 8(5):582-6. PubMed ID: 23470290
[TBL] [Abstract][Full Text] [Related]
14. Management of non-small-cell lung cancer: recent developments.
Reck M; Heigener DF; Mok T; Soria JC; Rabe KF
Lancet; 2013 Aug; 382(9893):709-19. PubMed ID: 23972814
[TBL] [Abstract][Full Text] [Related]
15. Second-line therapy in non-small-cell lung cancer: the DELTA between different genotypes widens.
Zer A; Leighl NB
J Clin Oncol; 2014 Jun; 32(18):1874-81. PubMed ID: 24841982
[No Abstract] [Full Text] [Related]
16. Thymidylate synthase gene amplification predicts pemetrexed resistance in patients with advanced non-small cell lung cancer.
Shimizu T; Nakagawa Y; Takahashi N; Hashimoto S
Clin Transl Oncol; 2016 Jan; 18(1):107-12. PubMed ID: 26220094
[TBL] [Abstract][Full Text] [Related]
17. Lung Carcinoma Predictive Biomarker Testing by Immunoperoxidase Stains in Cytology and Small Biopsy Specimens: Advantages and Limitations.
Zhou F; Moreira AL
Arch Pathol Lab Med; 2016 Dec; 140(12):1331-1337. PubMed ID: 27588333
[TBL] [Abstract][Full Text] [Related]
18. DNA repair and survival in lung cancer--the two faces of Janus.
Gazdar AF
N Engl J Med; 2007 Feb; 356(8):771-3. PubMed ID: 17314336
[No Abstract] [Full Text] [Related]
19. Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
D'Addario G; Früh M; Reck M; Baumann P; Klepetko W; Felip E;
Ann Oncol; 2010 May; 21 Suppl 5():v116-9. PubMed ID: 20555059
[No Abstract] [Full Text] [Related]
20. Role of Adjuvant Thoracic Radiation Therapy and Full Dose Chemotherapy in pN2 Non-small Cell Lung Cancer: Elucidation Based on Single Institute Experience.
Park H; Oh D; Ahn YC; Pyo H; Noh JM; Sun JM; Ahn JS; Ahn MJ; Park K; Kim HK; Choi YS; Kim J; Zo JI; Shim YM
Cancer Res Treat; 2017 Oct; 49(4):880-889. PubMed ID: 28052657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
